Abstract | BACKGROUND: Currently, although only a few therapies normalize the liver test abnormalities with/without improving the liver histology, no pharmacologic therapy has proved to be effective for the treatment of non- alcoholic steatohepatitis. AIM: METHODS: A total of 74 individuals with NASH (male/female, 44/30; mean age, 47.2 +/- 9.0 years) were enrolled. Participants were divided into two distinct groups: group 1 (n = 25) participants were administered a conventional diet and exercise programme while those in group 2 (n = 49) were administered the diet and exercise programme plus insulin sensitizers. RESULTS: With respect to baseline metabolic, biochemical and histological parameters, no significant differences were observed between the two groups (P > 0.05). Insulin sensitizers significantly improved metabolic parameters (homeostasis model assessment- insulin resistance score, P < 0.05), serum aminotransferase levels [ aspartate aminotransferase (AST): 45.9 +/- 24.2 to 33.3 +/- 17.7 IU/L, P < 0.01; alanine aminotransferase (ALT): 78.2 +/- 46.3 to 47.3 +/- 34.5 IU/L, P < 0.001] and histological features (median non-alcoholic fatty liver disease activity score: 5.0-3.0, P = 0.01), while diet and exercise improved serum aminotransferase levels (AST: 39.3 +/- 11.1 to 30.0 +/- 8.6 IU/L, P < 0.01; ALT: 66.9 +/- 28.9 to 42.0 +/- 16.2 IU/L, P < 0.001) at the end of the 48 weeks when compared to baseline. Insulin sensitizers improved the high-sensitivity C-reactive protein levels (P < 0.01). No serious adverse effects of insulin sensitizers were observed. CONCLUSION:
Insulin sensitizers can lead to improvement in metabolic, biochemical and histological abnormalities of NASH as a result of improved insulin sensitivity.
|
Authors | R Idilman, D Mizrak, D Corapcioglu, M Bektas, B Doganay, M Sayki, S Coban, E Erden, I Soykan, R Emral, A R Uysal, A Ozden |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 28
Issue 2
Pg. 200-8
(Jul 2008)
ISSN: 1365-2036 [Electronic] England |
PMID | 18445142
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Hypoglycemic Agents
- Thiazolidinediones
- Rosiglitazone
- Metformin
- Aspartate Aminotransferases
- Alanine Transaminase
|
Topics |
- Adult
- Alanine Transaminase
(blood, metabolism)
- Aspartate Aminotransferases
(blood, metabolism)
- Diet Therapy
- Exercise Therapy
- Fatty Liver
(drug therapy)
- Female
- Follow-Up Studies
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Insulin Resistance
- Male
- Metformin
(therapeutic use)
- Middle Aged
- Rosiglitazone
- Thiazolidinediones
(therapeutic use)
- Treatment Outcome
|